Modis Therapeutics - Ownership and Business Overview

Life ScienceCompany

Modis Therapeutics Ownership

Who owns Modis Therapeutics?

Modis Therapeutics is owned by Zogenix. It was acquired on August 26, 2019.

Was Modis Therapeutics formerly PE-backed?

Yes. Modis Therapeutics was formerly owned by 1 private investor.

Modis Therapeutics Business Overview

Where is Modis Therapeutics headquartered?

Modis Therapeutics is headquartered in Oakland, California.

What sector is Modis Therapeutics in?

Modis Therapeutics is a life science company.

When was Modis Therapeutics founded?

Modis Therapeutics was founded in 2016.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 251 acquisitions of life science companies in 2019, including 44 acquisitions by private equity firms, and 207 by strategics.

Modis Therapeutics

Modis Therapeutics, Inc.

409 13th Street, Suite 700,
Oakland, California 94612
United States,
(510) 806-8562
www.modistx.com

Modis Therapeutics is a biopharmaceutical company focused on developing disease-modifying therapies for rare genetic diseases with a high unmet medical need. Modis program (MT1621) is in clinical development for TK2d, an inherited mitochondrial disease. Modis Therapeutics was founded in 2016 and is headquartered in Oakland, California, with offices in New York City.


 Subscribe to unlock this and 208,107
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.